Kutane Nebenwirkungen zielgerichteter onkologischer Arzneimittel
Crossref DOI link: https://doi.org/10.1007/s00105-016-3902-3
Published Online: 2016-11-24
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Below, J.
Homey, B.
Gerber, P. A.
License valid from 2016-11-24
